No Data
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Beam Therapeutics Gets Upgrade From Leerink Partners; Shares Rise
H.C. Wainwright Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $80
CRISPR Technology Market Report 2024, With Profiles of Major Players Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Crispr Therapeutics, Danaher, Genscript, Lonza and More - ResearchAndMarkets.com
Beam Therapeutics Is Maintained at Sector Perform by RBC Capital
Beam Stock Rebounds as Leerink Upgrades Despite Fatality in Gene Editing Trial
No Data
No Data
Bunny R :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
TheOracleOfHindSight : If Harris wins im selling everything & investing in Gold
Tonyco :
Joe P :
tough Platypus_9271 : Harris will say anything to get elected . She has no experience in anything but a prosecutor for California and you see how that went. The emergent.czar , you see how that went too. If she is president, she will not be in charge, she knows nothing about the job, and you really want her to sit down with Putin? This is the worst time to even consider her. Watch the debate tonight at 9 eastern time.
View more comments...